- /
- Supported exchanges
- / DU
- / TN8.DU
THERMO FISHER SCIEN (TN8 DU) stock market data APIs
THERMO FISHER SCIEN Financial Data Overview
There is no Profile data available for TN8.DU.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get THERMO FISHER SCIEN data using free add-ons & libraries
Get THERMO FISHER SCIEN Fundamental Data
THERMO FISHER SCIEN Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
THERMO FISHER SCIEN News
New
Jim Cramer Said These 2 Stocks Were Sold Because Of A Rotation – But Is He Right?
Life sciences solutions and products provider Thermo Fisher Scientific (NYSE:TMO)'s shares have done well in September and are up by more than 8% since the 10th. On the 15th, Cramer discussed the stre...
Thermo Fisher Scientific (TMO) is Positioned for Resurgence
Fenimore Asset Management, an investment management company, released its Q2 2026 investor letter. You can download the letter here. U.S. equity markets saw broad gains in Q2, driven by strong corpora...
Genomics Market Outlook 2026-2035 - Featuring Profiles of Illumina, Thermo Fisher Scientific, and Qiagen
Company Logo AI, Advanced Sequencing and Precision Medicine Drive Genomics Opportunities Across Diagnostics, Drug Development and Preventive Care Dublin, Sept. 18, 2026 (GLOBE NEWSWIRE) -- "Genomics...
Pharmacogenomics Market Outlook 2026-2035 - Featuring Profiles of Thermo Fisher Scientific, Illumina, and Qiagen
Company Logo Pharmacogenomics Expands as Multi-Gene Testing, Bioinformatics and Precision Diagnostics Drive Clinical Adoption Dublin, Sept. 18, 2026 (GLOBE NEWSWIRE) -- "Pharmacogenomics Market Oppo...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.